Gateway 2011: MPI Research - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: MPI Research


Your online Gateway to MPI Research in 2011!

MPI Research
Corporate Headquarters
54943 North Main Street
Mattawan, MI 49071 USA

Phone: +1.269.668.3336
Fax: +1.269.668.4151
www.mpiresearch.com

Don't miss MPI Research at AAPS, October 23-27 in Washington, DC!


About MPI Research


MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, agricultural, environmental, and chemical industries. Specialized analytical testing services are available in Mattawan as well as at the State College, PA, facility. Scientific knowledge and experience, quick turnaround, and dedication to strong and enduring customer relationships characterize MPI Research as a high-performance, high-quality organization committed to bringing safer and more effective products to the world. Learn more about how we can exceed your expectations at www.mpiresearch.com.

Visit our Booth: # 305
We look forward to greeting you at AAPS in booth 305 and discussing how we can help move your drug development projects forward. Also be sure to attend the following presentations:

  • Poster Title:  Validation of a Bioanalytical ICP-MS Method for Quantification of Potassium in Human Urine
  • Symposium Session Title: Formulation Quality Control Issues In Nonclinical Dosing (#171) featuring Monica Whitmire’s
    Symposium Presentation:  Is it a Solution or a Suspension? Repercussions for NCDFA

 

New Products and Releases

Derrington Named President and COO

Development of a Ligand-Binding Assay
Analytical and Bioanalytical Options for the Preclinical Evaluation of Protein Biologics Using LC-MS/MS for the Bioanalysis of Proteins
Current Trends in Developmental and Reproductive Toxicology Symposium Options for Bioanalysis at MPI Research— Immunoassay and LC-MS/MS Techniques

Leading the Way with the SEND Initiative

Gyros Gyrolab™ offers Analytical Testing Advantages

 

 



 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here